|Title:||Fees and Charges related to the Diagnosis and Management of Tuberculosis and Leprosy|
|Document ID:||Operational Directive OD 0229/09|
|Date of issue:||Saturday, 7 November 2009|
|Description:||OD advises Health Services that patients must not incur any financial costs for the investigation of possible tuberculosis or leprosy, or the management and treatment of proven TB or leprosy.|
|Framework:||Public Health Policy Framework|
|Period of effect:||from 11 September 2009 to 30 September 2014|
|Review date:||30 September 2014|
|Authorised by:||Dr Peter Flett, Director General, DEPARTMENT OF HEALTH, 15-Sep-2009|
|Print version:||View print version|
Fees and Charges related to the Diagnosis and Management of Tuberculosis and Leprosy
This operational directive advises Health Services that patients must not incur any financial cost for the investigation of possible tuberculosis (TB) or leprosy, or the management and treatment of proven TB or leprosy.
A key strategy in the control of chronic infectious mycobacterial diseases (TB and Leprosy) is the prompt and effective free treatment. Ensuring that there is no financial barrier to investigation or treatment of these infections enables attendance and compliance, and thereby reduces the risk of delayed diagnosis or poorly treated infection, and therefore transmission within the community.
This policy is in line with the National Strategic Plan for TB in Australia: Beyond 2000 [National Tuberculosis Advisory Committee].
All fees and charges associated with TB and Leprosy management are to be waivered by the Health Service managing the care of the client. These include, but are not exclusive of, radiology, pathology, pharmacy and inpatient charges.
All Public Hospital Pharmacies are required to provide drugs used for the treatment of TB or leprosy free of any charge to the patient. The treating physician should annotate prescriptions to indicate that the drugs are for the treatment of TB and Leprosy, and should therefore be dispensed free of charge.
Accounts for tests or inpatient charges in patients suspected of, or diagnosed with TB or Leprosy, should be waived. This policy especially applies to patients that are not Medicare eligible. Patients that receive accounts for these services should be advised to not pay them, and the treating physician should apply to the Director of Clinical Services in the relevant Health Service for the account to be waived.
Patients may be referred to the Tuberculosis Control Program for free investigation, drug therapy or management for TB and Leprosy.
All enquiries regarding Fees and Charges related Tuberculosis and Leprosy can be directed to the Tuberculosis Control Program on 9219 3222.
Dr Peter Flett
This circular last updated: Friday, 6 November 2009 at 11:51am